Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.

Gungordu S., Aptullahoglu E.

Investigational new drugs, vol.42, no.6, pp.603-611, 2024 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 42 Issue: 6
  • Publication Date: 2024
  • Doi Number: 10.1007/s10637-024-01473-9
  • Journal Name: Investigational new drugs
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, ABI/INFORM, BIOSIS, Biotechnology Research Abstracts, CINAHL
  • Page Numbers: pp.603-611
  • Bilecik Şeyh Edebali University Affiliated: Yes